Abstract C106: Enhanced characterization of molecular attributes through multi-omics analysis and comprehensive evaluation of global and local genomic ancestry in colorectal cancer among Hispanic-Latinos
Enrique Velazquez‐Villarreal(City Of Hope National Medical Center), John D. Carpten(City of Hope), Carmen Chávez, Elizabeth Quino(LAC+USC Medical Center), Donna Loza(University of Southern California), Yonatan Amzaleg(City of Hope), Heinz‐Josef Lenz(USC Norris Comprehensive Cancer Center), Mariana C. Stern(University of Southern California), Julie O. Culver(City of Hope), David W. Craig(City of Hope), Brigette Waldrup(Keck Hospital of USC), Yuxin Jin(Chongqing University), Serina Ovalle(LAC+USC Medical Center), Mackenzie Postel(University of Southern California)
Cited by 0
Related Papers
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
|The Lancet Oncology|2017|2.8k
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2018|2.1k
Prognostic and Predictive Relevance of Primary Tumor Location in Patients With <i>RAS </i>Wild-Type Metastatic Colorectal Cancer
|JAMA Oncology|2016|722
The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth
|Journal of Clinical Investigation|2005|524